Yes. Single-agent trials are a simpler case of the same engine. Attribution still runs through WHO-UMC and Kramer, but with one drug the probability scores collapse to the single agent. The grading, citation, and audit trail behaviour is identical to combination regimens.
Interactive demo
Try Burna right now, no sign up required.